Min Lu

2.9k total citations · 2 hit papers
32 papers, 1.4k citations indexed

About

Min Lu is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Min Lu has authored 32 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Cancer Research and 7 papers in Genetics. Recurrent topics in Min Lu's work include Cancer, Hypoxia, and Metabolism (10 papers), Glioma Diagnosis and Treatment (7 papers) and Epigenetics and DNA Methylation (4 papers). Min Lu is often cited by papers focused on Cancer, Hypoxia, and Metabolism (10 papers), Glioma Diagnosis and Treatment (7 papers) and Epigenetics and DNA Methylation (4 papers). Min Lu collaborates with scholars based in United States, China and Netherlands. Min Lu's co-authors include David S. Hsu, David W. Threadgill, Robert J. Coffey, Reade B. Roberts, Stephen H. Settle, M. Kay Washington, Sydney M. Sanderson, Jason W. Locasale, Amy Ciccarella and Ana Calcagnotto and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Min Lu

31 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dietary methionine influences therapy in mouse cancer models and alters human metabolism

2019 439 citations Xia Gao, Sydney M. Sanderson et al. Nature profile →
Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial

2023 111 citations Ingo K. Mellinghoff, Min Lu et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Min Lu United States	14	669	368	340	234	198	32	1.4k
Dinesh Thotala United States	27	1.0k 1.5×	440 1.2×	210 0.6×	295 1.3×	100 0.5×	61	1.9k
Oona Delpuech United Kingdom	20	1.1k 1.6×	433 1.2×	460 1.4×	243 1.0×	162 0.8×	33	1.7k
Adriana Aguilar‐Mahecha Canada	19	835 1.2×	420 1.1×	637 1.9×	169 0.7×	124 0.6×	43	1.7k
Fabiola Moretti Italy	25	1.1k 1.6×	650 1.8×	270 0.8×	129 0.6×	95 0.5×	59	1.7k
Roch‐Philippe Charles Switzerland	22	1.0k 1.5×	447 1.2×	342 1.0×	192 0.8×	115 0.6×	35	1.9k
Nicole R. Murray United States	26	1.4k 2.1×	637 1.7×	381 1.1×	211 0.9×	186 0.9×	47	2.1k
Suzanne E. Williams United States	12	807 1.2×	215 0.6×	651 1.9×	143 0.6×	244 1.2×	18	1.9k
Estefanía Carrasco‐García Spain	25	817 1.2×	387 1.1×	412 1.2×	116 0.5×	73 0.4×	37	1.4k
Su Yeon Lee South Korea	15	774 1.2×	378 1.0×	510 1.5×	154 0.7×	88 0.4×	27	1.2k
Jessica E.S. Shay United States	11	903 1.3×	183 0.5×	932 2.7×	128 0.5×	87 0.4×	22	1.5k

Countries citing papers authored by Min Lu

Since Specialization

Citations

This map shows the geographic impact of Min Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Lu more than expected).

Fields of papers citing papers by Min Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Lu. The network helps show where Min Lu may publish in the future.

Co-authorship network of co-authors of Min Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Min Lu. A scholar is included among the top collaborators of Min Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Lu. Min Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wardell, Suzanne E., et al.. (2024). PKN2 Is a Dependency of the Mesenchymal-like Cancer Cell State. Cancer Discovery. 15(3). 595–615.

Lu, Min, et al.. (2024). Targeting HSP90 in Gynecologic Cancer: Molecular Mechanisms and Therapeutic Approaches. Cell Biochemistry and Biophysics. 83(1). 177–192. 3 indexed citations

Mellinghoff, Ingo K., Min Lu, Patrick Y. Wen, et al.. (2023). Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial. Nature Medicine. 29(3). 615–622. 111 indexed citations breakdown →

Ali, Moiez, Min Lu, Ryan S. Soderquist, et al.. (2022). Small-molecule targeted therapies induce dependence on DNA double-strand break repair in residual tumor cells. Science Translational Medicine. 14(638). eabc7480–eabc7480. 29 indexed citations

Chuntova, Pavlina, Akane Yamamichi, Rohini Narayanaswamy, et al.. (2022). Inhibition of D-2HG leads to upregulation of a proinflammatory gene signature in a novel HLA-A2/HLA-DR1 transgenic mouse model of IDH1R132H-expressing glioma. Journal for ImmunoTherapy of Cancer. 10(5). e004644–e004644. 23 indexed citations

Yang, Yuanyuan, et al.. (2021). Silencing of OIP5-AS1 Protects Endothelial Cells From ox-LDL-Triggered Injury by Regulating KLF5 Expression via Sponging miR-135a-5p. Frontiers in Cardiovascular Medicine. 8. 596506–596506. 7 indexed citations

Mellinghoff, Ingo K., Martin J. van den Bent, Jennifer Clarke, et al.. (2020). RTID-05. INDIGO: A GLOBAL, RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY OF VORASIDENIB (AG-881) VS PLACEBO IN PATIENTS WITH RESIDUAL/RECURRENT GRADE II GLIOMA WITH AN ISOCITRATE DEHYDROGENASE 1/2 (IDH1/2) MUTATION. Neuro-Oncology. 22(Supplement_2). ii194–ii194. 2 indexed citations

Gao, Xia, Sydney M. Sanderson, Ziwei Dai, et al.. (2019). Dietary methionine influences therapy in mouse cancer models and alters human metabolism. Nature. 572(7769). 397–401. 439 indexed citations breakdown →

Wang, Yanmei, et al.. (2019). Effects of continuous care for patients with type 2 diabetes using mobile health application: A randomised controlled trial. The International Journal of Health Planning and Management. 34(3). 1025–1035. 37 indexed citations

10.

Soderquist, Ryan S., Lorin Crawford, Esther Liu, et al.. (2018). Systematic mapping of BCL-2 gene dependencies in cancer reveals molecular determinants of BH3 mimetic sensitivity. Nature Communications. 9(1). 3513–3513. 90 indexed citations

11.

Wang, Jiangbo, Robert A. Mook, Xiu-Rong Ren, et al.. (2018). Identification of DK419, a potent inhibitor of Wnt/β-catenin signaling and colorectal cancer growth. Bioorganic & Medicinal Chemistry. 26(20). 5435–5442. 13 indexed citations

12.

Lu, Min, Sydney M. Sanderson, Kathleen A. Ashcraft, et al.. (2018). Exercise inhibits tumor growth and central carbon metabolism in patient-derived xenograft models of colorectal cancer. SHILAP Revista de lepidopterología. 6(1). 14–14. 30 indexed citations

13.

Lu, Min, et al.. (2017). Activation of the mTOR Pathway by Oxaliplatin in the Treatment of Colorectal Cancer Liver Metastasis. PLoS ONE. 12(1). e0169439–e0169439. 38 indexed citations

14.

Tang, Xiaohu, Jianli Wu, Chien‐Kuang Cornelia Ding, et al.. (2016). Cystine Deprivation Triggers Programmed Necrosis in VHL-Deficient Renal Cell Carcinomas. Cancer Research. 76(7). 1892–1903. 67 indexed citations

15.

Ketter, Nzeera, Di Jiang, Lawrence S. Honig, et al.. (2016). A RANDOMIZED, DOUBLE-BLIND, PHASE 2 STUDY OF THE EFFECTS OF THE VACCINE VANUTIDE CRIDIFICAR WITH QS-21 ADJUVANT ON IMMUNOGENICITY, SAFETY AND AMYLOID IMAGING IN PATIENTS WITH MILD TO MODERATE ALZHEIMER’S DISEASE. The Journal of Prevention of Alzheimer s Disease. 3(4). 1–10. 22 indexed citations

16.

Song, Junmin, Min Lu, Fangfang Liu, Xiaojuan Du, & Baocai Xing. (2011). AIB1 as an Independent Prognostic Marker in Hepatocellular Carcinoma After Hepatic Resection. Journal of Gastrointestinal Surgery. 16(2). 356–360. 6 indexed citations

17.

Lu, Min, et al.. (2010). The production operation model of rice-duck culture and its SWOT analysis in Jilin province.. Guizhou nongye kexue. 224–226. 1 indexed citations

18.

Wang, Zuoren, et al.. (2004). Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: In comparison with CEA. World Journal of Gastroenterology. 10(3). 427–427. 141 indexed citations

19.

Lu, Min, et al.. (2004). [Clinical study of adjuvant individualized chemotherapy for hepatocellular carcinoma after liver transplantation].. PubMed. 42(17). 1040–3. 5 indexed citations

20.

Ju, Wei, et al.. (2003). [The clinical management of cardiovascular complications after orthotopic liver transplantation].. PubMed. 11(12). 749–51. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact